Rockwell Medical, Inc. (NASDAQ:RMTI) Short Interest Update

Rockwell Medical, Inc. (NASDAQ:RMTI) was the recipient of a large increase in short interest in the month of February. As of February 13th, there was short interest totaling 818,620 shares, an increase of 19.3% from the January 29th total of 686,242 shares. Based on an average daily volume of 278,814 shares, the days-to-cover ratio is presently 2.9 days. Currently, 2.1% of the shares of the company are sold short. Currently, 2.1% of the shares of the company are sold short. Based on an average daily volume of 278,814 shares, the days-to-cover ratio is presently 2.9 days.

Analyst Ratings Changes

RMTI has been the subject of several research reports. HC Wainwright reissued a “buy” rating and issued a $2.50 price objective on shares of Rockwell Medical in a research report on Monday, January 26th. Wall Street Zen lowered shares of Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Saturday, November 15th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Rockwell Medical in a research report on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Rockwell Medical has a consensus rating of “Hold” and a consensus price target of $2.50.

Rockwell Medical Trading Down 0.2%

Shares of RMTI stock opened at $0.89 on Friday. The firm has a fifty day moving average of $1.00 and a 200-day moving average of $1.10. The stock has a market cap of $35.07 million, a price-to-earnings ratio of -5.56 and a beta of 1.71. Rockwell Medical has a 52-week low of $0.78 and a 52-week high of $2.10. The company has a debt-to-equity ratio of 0.25, a quick ratio of 3.50 and a current ratio of 3.91.

Institutional Investors Weigh In On Rockwell Medical

Several large investors have recently modified their holdings of the stock. Panagora Asset Management Inc. bought a new position in shares of Rockwell Medical during the 2nd quarter worth approximately $41,000. XTX Topco Ltd raised its stake in Rockwell Medical by 286.5% during the fourth quarter. XTX Topco Ltd now owns 62,097 shares of the company’s stock worth $52,000 after acquiring an additional 46,029 shares in the last quarter. Jane Street Group LLC acquired a new position in Rockwell Medical during the fourth quarter worth $84,000. GSA Capital Partners LLP lifted its holdings in shares of Rockwell Medical by 635.1% during the third quarter. GSA Capital Partners LLP now owns 163,978 shares of the company’s stock valued at $197,000 after acquiring an additional 141,672 shares during the period. Finally, Geode Capital Management LLC boosted its stake in shares of Rockwell Medical by 12.9% in the 4th quarter. Geode Capital Management LLC now owns 364,816 shares of the company’s stock valued at $304,000 after purchasing an additional 41,668 shares in the last quarter. 23.31% of the stock is currently owned by institutional investors.

About Rockwell Medical

Rockwell Medical, Inc is a Delaware?domiciled biopharmaceutical company focused on the development and commercialization of therapies for patients with chronic kidney disease (CKD). The company’s mission centers on addressing common complications in CKD—namely iron deficiency and secondary hyperparathyroidism—through innovative treatment approaches designed for dialysis settings.

The company’s lead product, TRIFERIC®, is an iron replacement therapy approved by the U.S. Food and Drug Administration for use in hemodialysis patients.